ALKS Insider Trading Activity and SEC Form 4 Filings
Trump's trades in ALKS
From his financial disclosures
$66K+
3 purchases
$66K+
3 sales
Sale
Jul 29, 2026
Reported 55d later
$50K - $100K
Purchase
Jun 15, 2026
Reported 68d later
$1K - $15K
Sale
May 15, 2026
Reported 47d later
$1K - $15K
Purchase
Mar 30, 2026
Reported 45d later
$50K - $100K
Sale
Feb 26, 2026
Reported 77d later
$15K - $50K
Purchase
Jan 26, 2026
Reported 108d later
$15K - $50K
Many orders in these accounts are placed by the account manager.
ALKS insider trading summary
Over the past 12 months, insiders at Alkermes plc. (ALKS) reported 32 sales worth $9.7M by 7 insiders and no open-market purchases on SEC Form 4. Net insider selling was $9.7M.
Latest ALKS insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 3, 2026 | David Joseph Gaffin | EVP, CLO, Alkermes, Inc. | Sell | $94K (2,035 @ $46.17) |
| Oct 2, 2026 | David Joseph Gaffin | EVP, CLO, Alkermes, Inc. | Sell | $83K (2,034 @ $41.03) |
| Sep 3, 2026 | David Joseph Gaffin | EVP, CLO, Alkermes, Inc. | Sell | $98K (2,034 @ $48.01) |
| Sep 1, 2026 | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Sell | $423K (9,000 @ $46.99) |
| Aug 17, 2026 | Christian Todd Nichols | SVP, Chief Commercial Officer | Sell | $340K (6,912 @ $49.19) |
| Aug 17, 2026 | Christian Todd Nichols | SVP, Chief Commercial Officer | Sell | $33K (664 @ $49.65) |
| Aug 3, 2026 | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Sell | $437K (9,000 @ $48.58) |
| Aug 3, 2026 | David Joseph Gaffin | EVP, CLO, Alkermes, Inc. | Sell | $99K (2,034 @ $48.58) |
| Aug 3, 2026 | nancy lynn MD snyderman | Director | Sell | $2.2M (44,472 @ $50.35) |
| Jul 6, 2026 | David Joseph Gaffin | EVP, CLO, Alkermes, Inc. | Sell | $110K (2,034 @ $54.03) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.